Literature Review

Vol. 9 No. 3 (2022): European Journal of Rheumatology

Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease

Main Article Content

Cemal Bes
Gizem Köybaşı
Ozan Cemal İçaçan
Melek Yalçın Mutlu
Fatih Yıldırım

Abstract

bstract Interstitial lung disease (ILD) is one of the common extra-articular manifestations of rheumatoid arthritis (RA) and it is associated with high mortality rate. The usual interstitial pneumonia (UIP) pattern of RA associated ILD (RA-ILD) shows some similarities to idiopathic pulmonary fibrosis, suggesting that antifibrotic therapies may have potential positive affects. In this review, we discuss the effectiveness of antifibrotic therapy for RA-ILD.



Cite this article as: Bes C, Köybaşı G, İçaçan OC, Mutlu MY, Yıldırım F. Influence of anti-TNF-a treatment on liver and kidney functions in patients with ankylosing spondylitis: A retrospective longitudinal study. Eur J Rheumatol. 2022;9(3):176-179.


Article Details